Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Scientific journals
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Scientific journals
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News

View allDDup 11Press ReleasePublicationsScientific journalsWebinarsWhite Papers & Application Notes

Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse

Press ReleaseApril 20, 2021

J.POD® 2 EU biomanufacturing will play a key role in addressing the need for therapeutic antibodies, including those related to infectious diseases such as COVID-19

Learn more

G-CON Manufacturing and Just – Evotec Biologics Complete the Installation of Cleanroom PODs® for the First J.POD®  Facility in North America

Press ReleaseMarch 16, 2021

Just – Evotec Biologics’ Redmond, Washington site offers true meaning to “Facility of the Future” with flexible and podular manufacturing of clinical and commercial-stage biologics.…

Learn more

Just – Evotec Biologics Expands Contract  With Department of Defense For Manufacturing of Monoclonal Antibodies

Press ReleaseJanuary 27, 2021

Just – Evotec Biologics will manufacture anti-SARS-CoV-2 and other antibodies at its J.POD® manufacturing facility. Access to manufacturing capacity over a period of 7 years

Learn more

Evotec Partners With Alloy Therapeutics  to Expand its Antibody Discovery Platform

Press ReleaseDecember 21, 2020

Evotec gains access to Alloy Therapeutics’ ATX-Gx™ humanised mouse platform for biologics discovery Partnership leverages complementary strengths of in silico, in vitro and in vivo…

Learn more

Just – Evotec Biologics Receives Grant To Enable An Antibody Product For The Prevention Of COVID-19

Press ReleaseOctober 19, 2020

Just – Evotec Biologics receives grant for COVID-19 monoclonal antibody optimisation and cell line development from the COVID-19 therapeutics accelerator Grant enables the optimisation of…

Learn more

Biologics manufacturing without the big bioreactors

Scientific journalsSeptember 28, 2020

Producing therapeutic antibodies is expensive and difficult, but drug-makers have unprecedented flexibility in plant design through a new modular biologics manufacturing platform that streamlines the…

Learn more

Just – Evotec Biologics to Produce Monoclonal Antibody Products Against COVID-19 for The Department of Defense

Press ReleaseJuly 22, 2020

Just – Evotec Biologics to provide process development and manufacturing of monoclonal antibody

Learn more

Just – Evotec Biologics Partners with ABL on Development of Broadly Neutralising Antibody Against HIV

Press ReleaseJune 8, 2020

Just – Evotec Biologics to provide process development required for phase I cGMP clinical manufacturing of broadly neutralising antibody against HIV

Learn more

Just – Evotec Biologics to Collaborate with Ology Bioservices on Antibodies against Coronavirus

Press ReleaseApril 30, 2020

Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention…

Learn more

Designing Feature-Controlled Humanoid Antibody Discovery Libraries Using Generative Adversarial Networks

Publications, Scientific journalsApril 13, 2020

Just – Evotec Biologics has compiled a library of a new class of humanoid antibodies using a novel, AI-derived approach. Antibodies are proteins produced and…

Learn more

CoreAb Sequence Classification

White Papers & Application NotesMarch 12, 2020

A methodology has been developed for the structural alignment and classification of full sequences from antibodies and antibody-like structures using the Antibody Structural Numbering system…

Learn more

Just – Evotec Biologics Announces Product Development and Manufacturing Agreement With OncoResponse

Press ReleaseJanuary 16, 2020

Just – Evotec Biologics will apply its fully integrated technology platform in order to accelerate Oncoresponse’s lead product candidate through development and into the clinic

Learn more
1234
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2022 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top